Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine

Press/Media

Period	22 Mar 2022

Media coverage

Title	Mount Sinai launches phase 1 study to evaluate the safety, immunogenicity of egg-based COVID-19 vaccine
Media name/outlet	News-Medical.Net
Country/Territory	Australia
Date	22/03/22
URL	https://www.news-medical.net/news/20220321/Mount-Sinai-launches-phase-1-study-to-evaluate-the-safety-immunogenicity-of-egg-based-COVID-19-vaccine.aspx
Persons	Judith Aberg, Sean Liu